Bibliographie (2546)
New Updates to the Surviving Sepsis Campaign COVID-19 Guidelines
lundi, 01 février 2021 03:59 Écrit par Zouhair SouissiSurviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU – Critical Care Medicine Additional resources: COVID-19 Guidelines – Surviving Sepsis Campaign Commentary on Twitter New updates to the #SurvivingSepsis Campaign #COVID19 Guidelines! Includes new recommendations for therapeutics and defines severe vs critical COVID-19. View the full […]
The post New Updates to the Surviving Sepsis Campaign COVID-19 Guidelines appeared first on Links Medicus.
![[Not published yet] Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials](/media/k2/items/cache/f964ddc910acbc5c426350c1b152e08d_L.jpg)
[Not published yet] Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials
lundi, 01 février 2021 03:59 Écrit par Zouhair SouissiFull-Dose Heparin Best for Moderate COVID-19 Regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials – MedPage Today (free registration required) Trial results: ATTACC, ACTIV-4a & REMAP-CAP multiplatform RCT Results of interim analysis – ATTACC Trial News release: Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 […]
The post [Not published yet] Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials appeared first on Links Medicus.
WHO announces updated definitions of extensively drug-resistant tuberculosis
vendredi, 29 janvier 2021 10:44 Écrit par Zouhair SouissiWHO announces updated definitions of extensively drug-resistant tuberculosis – World Health Organization Report: Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis
The post WHO announces updated definitions of extensively drug-resistant tuberculosis appeared first on Links Medicus.
How Covid-19 mutations are changing the pandemic
vendredi, 29 janvier 2021 10:44 Écrit par Zouhair SouissiHow Covid-19 mutations are changing the pandemic – BBC
The post How Covid-19 mutations are changing the pandemic appeared first on Links Medicus.
German officials say AstraZeneca vaccine shouldn’t be given to over-65s, citing lack of data
vendredi, 29 janvier 2021 10:44 Écrit par Zouhair SouissiGerman officials say AstraZeneca vaccine shouldn’t be given to over-65s, citing lack of data – CNN Commentary: Expert reaction to reports that guidance from STIKO in Germany has recommended the Oxford/AstraZeneca vaccine only for under 65s – Science Media Centre
The post German officials say AstraZeneca vaccine shouldn’t be given to over-65s, citing lack of data appeared first on Links Medicus.
New coronavirus variants call for intensified surveillance, control, and vaccination efforts
vendredi, 29 janvier 2021 10:44 Écrit par Zouhair SouissiNew coronavirus variants call for intensified surveillance, control, and vaccination efforts – STAT
The post New coronavirus variants call for intensified surveillance, control, and vaccination efforts appeared first on Links Medicus.
Long Covid: Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge
jeudi, 28 janvier 2021 06:17 Écrit par Zouhair SouissiRespiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge – JAMA Network Open Commentary: Lung, mobility problems plague COVID-19 patients months after recovery – UPI
The post Long Covid: Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge appeared first on Links Medicus.
Editorial: Covid-19 controversies: the Tocilizumab chapter
jeudi, 28 janvier 2021 06:17 Écrit par Zouhair SouissiCovid-19 controversies: the tocilizumab chapter – The BMJ Related: Contradicting earlier trials, Tocilizumab did not improve outcomes, with signs of harm, in patients with severe Covid-19 (studies and commentaries)
The post Editorial: Covid-19 controversies: the Tocilizumab chapter appeared first on Links Medicus.
Covid-19: Cough, fatigue, sore throat ‘more common’ in new variant
jeudi, 28 janvier 2021 06:17 Écrit par Zouhair SouissiCovid-19: Cough, fatigue, sore throat ‘more common’ in new variant – BBC Original report: Coronavirus (COVID-19) Infection Survey: characteristics of people testing positive for COVID-19 in England, 27 January 2021 – Office for National Statistics
The post Covid-19: Cough, fatigue, sore throat ‘more common’ in new variant appeared first on Links Medicus.
4 reasons we’re seeing these worrying coronavirus variants now – Covid-19 is evolving. Why now?
jeudi, 28 janvier 2021 06:17 Écrit par Zouhair Souissi4 reasons we’re seeing these worrying coronavirus variants now – Vox
The post 4 reasons we’re seeing these worrying coronavirus variants now – Covid-19 is evolving. Why now? appeared first on Links Medicus.
![[Preprint] Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19](/media/k2/items/cache/3d4417dea4b5985d283b0a7dfa9861de_XS.jpg)
![[Press release – not published yet] REGENERON reports positive interim data with antibody cocktail used as passive vaccine to prevent COVID-19](/media/k2/items/cache/423c23827096d15f6a3f90fd1a691b32_XS.jpg)
